Literature DB >> 9810960

Adult polyglucosan body disease associated with an extrapyramidal syndrome.

N P Robertson1, S Wharton, J Anderson, N J Scolding.   

Abstract

A 50 year old patient is described who presented with parkinsonism, frontal dementia, peripheral neuropathy, neurogenic bladder, and upper motor neuron signs. No improvement in objective measurements of extrapyramidal dysfunction were seen with an incremental apomorphine test or more prolonged oral dopamine challenge. Neurophysiology disclosed changes compatible with a diffuse axonal neuropathy and pathological examination of a length of sural nerve taken at biopsy showed multiple polyglucosan bodies characteristic of adult polyglucosan body disease (APGBD). This case underlines the diverse clinical presentation of this rare neurological disease and the importance of recognising the unusual association of clinical features in making the diagnosis. APGBD should be included in the differential diagnosis of parkinsonism unresponsive to dopaminergic therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9810960      PMCID: PMC2170328          DOI: 10.1136/jnnp.65.5.788

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  A case of adult polyglucosan body disease.

Authors:  Seung-Yeob Lee; Jae-Hyeon Park; So Hun Kim; Tai-Seung Kim; Won-Joo Kim; Young-Chul Choi
Journal:  Yonsei Med J       Date:  2007-08-31       Impact factor: 2.759

2.  Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV.

Authors:  H Orhan Akman; Tatiana Sheiko; Stacey K H Tay; Milton J Finegold; Salvatore Dimauro; William J Craigen
Journal:  Hum Mol Genet       Date:  2011-08-19       Impact factor: 6.150

3.  A novel mouse model that recapitulates adult-onset glycogenosis type 4.

Authors:  H Orhan Akman; Valentina Emmanuele; Yasemin Gülcan Kurt; Bülent Kurt; Tatiana Sheiko; Salvatore DiMauro; William J Craigen
Journal:  Hum Mol Genet       Date:  2015-09-18       Impact factor: 6.150

4.  ALS-Plus syndrome: non-pyramidal features in a large ALS cohort.

Authors:  Leo McCluskey; Shannon Vandriel; Lauren Elman; Vivianna M Van Deerlin; John Powers; Ashley Boller; Elisabeth McCarty Wood; John Woo; Corey T McMillan; Katya Rascovsky; Murray Grossman
Journal:  J Neurol Sci       Date:  2014-07-18       Impact factor: 3.181

Review 5.  Characterization of cognitive impairment in adult polyglucosan body disease.

Authors:  Paul Theo Zebhauser; Isabell Cordts; Holger Hengel; Bernhard Haslinger; Paul Lingor; Hasan Orhan Akman; Tobias B Haack; Marcus Deschauer
Journal:  J Neurol       Date:  2022-01-08       Impact factor: 6.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.